PHILADELPHIA – May 22, 2009 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback